The largest database of trusted experimental protocols

Hybri-Care is a specialized cell culture medium designed to support the growth and maintenance of hybridoma cells. It provides a balanced formulation of essential nutrients, growth factors, and other components necessary for optimal hybridoma cell performance.

Automatically generated - may contain errors

5 protocols using hybri care

1

Cell Line Cultivation and Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cells were obtained from the American Type Culture Collection. Cells were grown in DMEM (Panc-1, MiaPaCa-2), RPMI1640 (BxPC-3) or HybriCare (ATCC) with 30ng/ml epidermal growth factor (CCL-241, normal human small intestine epithelial cells) media supplemented with and 10% fetal bovine serum (Invitrogen), 2 mmol/L l-glutamine (Sigma) and penicillin/streptomycin (Sigma). Experiments were conducted on exponentially growing cells. Cells were tested for Mycoplasma once every 3 months. UMI77 was dissolved in DMSO and stored at − 20°C. Non-specific and Mcl-1 siRNAs were purchased from Dharmacon and used as previously described [10] (link). Cells were transfected with siRNA using Oligofectamine (Invitrogen) or X-treme gene (Roche) transfection reagents.
+ Open protocol
+ Expand
2

Cell Line Characterization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cancer cell lines were purchased from ATCC except for Huh7 (JCRB), PC-9 (Riken BRC), BEL7404 (SUZHOU BEILE BIOTECH), SK-OV-3, A2780, RPMI-8226 (ECACC), HCC78 (DSMZ) and KM-12 (HUATUO). Cell culture medium included RPMI-1640 (#22400-089), McCoy’s 5a (#16600082), DMEM (#11995-065), F-12K (#21127-022) and IMDM (#12440053) was purchased from Gibco. EMEM (#30-2003) and Hybri-Care (#46-X) medium was purchased from ATCC. Leibovitz’s L-15 (#L1518) was purchased from SIGMA. All the medium was contained 10% or 20% FBS (#FND500, ExCell Bio). The 2D and 3D models used the same culture medium. Horse serum (#041241A) was bought from BI. Trypsin (#25200072) and antibiotic-antimycotic (#15240-062) was purchased from Gibco. Dulbecco’s PBS (#21-031-CVC) and matrigel (#354234) were purchased from Corning. DMSO (#D2650) was bought from Sigma. CellTiter-Glo Cell Viability Assay kit (#G7573) and CellTiter-Glo 3D Cell Viability Assay kit (#G9683) were purchased from Promega.
+ Open protocol
+ Expand
3

Evaluating Cytotoxicity of PLL-Au-Fe3O4 NPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BT-474 and MDA-MB-231 breast cancer cells (ATCC) were cultured at 37 °C and 5% CO2 in Hybri-Care (ATCC) and RPMI 1640 (Life Technologies), respectively supplemented with 10% FBS (Corning) and 1% (100 units/ml) Penicillin–Streptomycin (Gibco). Cells in the exponential growth phase were seeded in a 96-well plate at an initial density of 10,000 cells/well and incubated overnight. Different concentrations of PLL–Au–Fe3O4 NPs (0–500 μg/ml) were added to the cell culture media. After 2 h of incubation, the media was removed, and the cells were washed using PBS followed by re-incubation in cell culture media for additional 72 h. The viable and dead cells were measured using a live–dead (calcein AM; CAM and EthD–1) assay (Invitrogen) and calculated according to the manufacturer’s protocol. The cells without any NP treatments were used as the control. The percentage cell death was calculated by the following equation: %celldeath=FNPs-FblankFcontrol-Fblank×100 where FNPs is the Ethd-1 fluorescence of the cells treated with PLL–Au–Fe3O4 NPs, Fblank is the Ethd-1 fluorescence of the cell culture medium alone, and Fcontrol is the Ethd-1 fluorescence of the cells without any NP treatments. The concentration at which cell death was less than 10% was identified as a non-toxic dose.
+ Open protocol
+ Expand
4

Establishing Trastuzumab-Resistant Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two trastuzumab-sensitive HER2+breast cancer cell lines SKBR3 and BT474 obtained from American Type Culture Collections (ATCC, Manassas, VA) were maintained in McCoy-5A and Hybri-Care (ATCC, Manassas, VA) growth medium plus 10% fetal bovine serine (Invitrogen, Carlsbad, CA), 50 units/mL penicillin and 50 μg/mL streptomycin in a 37 °C humidified incubator with 5% CO2. Subcultures were carried out when the cells were ~90% confluent.
To select resistant sublines, SKBR3 and BT474 cells were cultured in the presence of 200 μg/ml of trastuzumab (Genentech, San Francisco, CA) for over 12 months with medium refreshed every 3–4 days to allow the formation of resistant colonies.
+ Open protocol
+ Expand
5

Breast Cancer Cell Line Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
SK-BR-3, BT-474, MDA-MD-468, MDA-MB-453 and HCC1419 cell lines were obtained from American Type Culture Collection (Rockwell, MA).The JIMT-1 cells were a gift from Pravin Kaumaya, (The Ohio State University, Columbus OH). SKBR3 cells were cultured in McCoy’s 5A Media (Gibco) supplemented with 10% v/v fetal calf serum (FBS; BioWhittaker), 100 units/ml of potassium penicillin and 100 μg/ml of streptomycin sulfate (BioWhittaker). BT-474 cells were cultured in HybriCare (ATCC), supplemented with 10% v/v FBS, 100 units/ml of potassium penicillin and 100 ug/ml of streptomycin sulfate. MDA-MB-468, MDA-MB-453 and HCC1419 cells were cultured in RPMI-1640 (BioWhittaker), 10% v/v FBS, 100 units/ml of potassium penicillin and 100 ug/ml of streptomycin sulfate (BioWhittaker), 2mmol/L glutamine (BioWhittaker), 1mmol/L sodium pyruvate (BioWhittaker), and 1% non-essential amino acids (BioWhittaker). All cells were maintained in culture at 37°C in 5% CO2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!